&#xa0;
defaultWritten edefaultvidence defaultsubmitted bydefault the Society for Applied Microbiology default(AMR0036)default&#xa0;
defaultThe Society for Applied Microbiology
default (S
defaultf
defaultAM)
default is the oldest microbiology society in the UK. 
default&#xa0;
defaultS
defaultf
defaultAM envisages a future where applied microbiology research and development is strong in the UK and beyond, and the applications of microbiology contribute significantly to all global challenges facing humanity, including infectious diseases; the changing environment; sustainability of energy, food, water, and land resources; and economic growth.
default&#xa0;
defaultThis response is in addition to S
defaultf
defaultAM’s endorsement of the Society of Biology submission. S
defaultf
defaultAM is a member organization of the Society of Biology.
default&#xa0;
defaultQ. How has antimicrobial resistance developed in the past decade?
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultQ.
default&#xa0;
defaultWhat are the gaps in our knowledge about antimicrobial resistance?
default&#xa0;default&#xa0;
defaultIt will also be important to understand what resistance reservoir exists in normal human and animal commensal microbiota (even prior to any antibiotic exposure). 
default&#xa0;
defaultWe need to know:
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultQ. Is there sufficient research and investment into new antibiotics or other treatments and methods to ensure continued protection against infection? If not, how could this be rectified?
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultQ. What measures (including behavioural change) have been most effective in controlling the spread of resistant pathogens, and could such measures be used to control other pathogens?
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;
defaultQ. What global coordination and action is required to fight antimicrobial resistance and is the UK contributing enough towards cross-border initiatives?
default&#xa0;
default&#xa0;
defaultUK 1970 - The solution - Swann recommendations:
default&#xa0;
defaultEU 2006. Ban of use of growth promoters in animal feeds default‘Regulation 1831/2003/EC on additives for use in animal nutrition’ default‘This regulation will strengthen the EU’s rules on the safety of animal feed and complete the EU ban on the use of antibiotics as growth promoters Both these objectives are of major importance to the EU’s food safety strategy and indeed to wider considerations of animal health’
default defaultDavid Byrne, EU Commissioner for Health and Consumer Protection, 2006 default&#xa0;
defaultUK Chief Medical Officer Reports 2009, 2011 default‘
defaultThere should be a ban on the use of certain types of antibiotics (quinolones and cephalosporins) in animals, in order to protect their activity in humans’ 
defaultSir Liam Donaldson, CMO, 2009 default‘defaultN
defaultational approach to tackling antimicrobial resistance should be managed jointly between DH and Defra to ensure that a comprehensive integrated programme is developed’. 
defaultDame Sally Davies, CMO, 2013 default&#xa0;
defaultEuropean Food Safety Authority (EFSA), 2011 defaultScientific Opinion on the public health risks of bacterial strains producing ESBLsand/or AmpC β-lactamases in food and food-producing animals default‘A highly effective control option would be to stop all uses of cephalosporins/systemically active 3rd/4th generation cephalosporins, or to restrict their use (use only to be allowed under specific circumstances)’. 
default&#xa0;
defaultEuropean Parliament October 2011 default‘European Parliament calls upon the European Commission to make legislative proposals to phase out the prophylactic use of antibiotics in livestock farming in the EU’ 
defaultEuropean Parliament, 27 October 2011 default&#xa0;
defaultSANCO strategy on Antimicrobial Resistancedefault5-year strategy presented on European Antibiotic Awareness Day,18 November 2011 default defaultHolistic approach: public health, food safety, consumer safety, environment, animal health and welfare as well as non-therapeutic use of antimicrobials 
default&#xa0;
defaultWHO Europe strategy on antibiotic resistance defaultSeven action areas: default1. Promote national coordination 
default2. Strengthen surveillance 
default3. Promote rational use of antibiotics, including surveillance of antibiotic consumption 
default4. Improve infection control and stewardship of antibiotic use in health care settings 
default5. Promote surveillance, prevention and control of antibiotic resistance in the food chain 
default6. Promote research and innovation on new antibiotics 
default7. Improve awareness on antibiotic use and risk of increasing resistance 
default&#xa0;
defaultFighting antibiotic resistance a priority for WHO/Europe European strategy under development 
default2011 publication suggests actions for tackling antibiotic resistance from a food safety perspective default&#xa0;
defaultKey messages for countries default1. Improve overall coordination 
default2. Improve regulatory framework 
default3. Reduce the need for and promote prudent use of antibiotics 
default4. Improve surveillance 
default5. Advocate and communicate 
default6. Build capacity and provide training 
default7. Address knowledge gaps and research needs 
default&#xa0;
defaultWHO/FAO/OIE achievements on AMR since 1997 default&#xa0;
defaultCritically-Important Antimicrobials (CIAs) WHO, 2007, 2009, 2011 defaulte.g. Quinolones / flouroquinolones 3rd / 4th generation cephalosporins Carbapenams 
default&#xa0;
defaultCodex: defaultad hoc defaultIntergovernmental Task Force on AMR, 2007-2010default 
defaultObjectives default1. To assess the risks to human health associated with the presence in food and feed of antimicrobial resistant organisms, antimicrobial resistant genes or residues of antimicrobials 
default2. To develop risk management advice based on that assessment to reduce such a risk 
defaultOutcome: Guidelines for the Risk Analysis of Foodborne Antimicrobial Resistance defaultCodex Alimentarius: Strategic Plan 2008-2013default 
defaultDevelop guidance for safe and prudent non-human antimicrobial usage for containment of resistance default&#xa0;defaultDescription: defaultDevelop guidance within the remit of Codex mandate for safe and prudent antimicrobial usage for containment of resistance in food production which focuses on public health, is based on sound science and follows risk analysis principles, and takes into account the work of other international organizations. 
default&#xa0;defaultTimeline: defaultCompletion by 2011 
default&#xa0;defaultResponsible parties: defaultExisting relevant Codex Committees, 
defaultad hoc 
defaultIntergovernmental Task Force on Antimicrobial Resistance Codex Alimentarius: Strategic Plan 2008-2013 
default&#xa0;
default&#xa0;
defaultOIE List of Antimicrobials of Veterinary Importancedefault 
default&#xa0;defaultDefines: default•
defaultVeterinary Critically Important Antimicrobials 
default•
defaultVeterinary Highly Important Antimicrobials 
default•
defaultVeterinary Important Antimicrobials
default: 
default&#xa0;default‘Critically Important’ include: default•
defaultAminoglycosides 
default•
defaultCephalosporins 
default•
defaultMacrolodes 
default•
defaultQuinolones/ fluoroquinolones 
default&#xa0;
defaultGuidance on pre-approval information for registration of new veterinary medicinal products for food-producing animals with respect to antimicrobial resistancedefault default&#xa0;defaultHarmonized technical guidance in E.U., Japan and the U.S. for registration of antimicrobial veterinary medicinal products intended for use in food-producing animals ,with regard to characterization of potential for a given antimicrobial agent to select for resistant bacteria of human health concern. 
default&#xa0;
defaultInformation on: default•Antimicrobial class 
default•Mechanism and type of antimicrobial action 
default•Antimicrobial spectrum activity -MICs 
default&#xa0;
defaultEuropean Medicines Agency Press release, 16th April 2013 default‘Use of antibiotics in animals - European Medicines Agency to give advice to European Commission on public- and animal-health impact’ 
default&#xa0;
default•
default‘One health’ perspective default•
defaultMultidisciplinary working group default•
defaultScientific basis to inform decisions default•
defaultFirst report, June 2013 default•
defaultFinal report, June 2014 default&#xa0;
defaultOctober 2011 ‘European Parliament calls upon the European Commission to make legislative proposals to phase out the prophylactic use of antibiotics in livestock farming in the EU’ defaultEuropean Parliament, 27 October 2011 default&#xa0;defaultUK, January 2011: Similar proposal made during House of Commons debate on antibiotic use on intensive farmsdefault 
defaultHouse of Commons, 9 January 2013default. 
default&#xa0;
defaultRUMA defaultPress statement 26 March 2013 default default&#xa0;
defaultPreventive treatment (sometimes referred to as Prophylaxis) default‘Treatment with antibiotics of an animal or a group of animals, before clinical signs of infectious disease, in order to prevent the occurrence of disease or infection’. 
default•
defaultMust only be applied to animals diagnosed at high risk of bacterial disease, default•
defaultMust only occur under prescription by veterinarian on basis of epidemiological and clinical knowledge, default•
defaultMust not be applied systematically or routinely, default•
defaultMust not be used to compensate for poor hygiene or for inadequate husbandry conditions, or where improvements in animal husbandry could reduce need for antibiotic treatment. default&#xa0;
defaultFood industry perspectivedefaultThe British Poultry Council have introduced a voluntary ban on the use of fluoroquinolones and 3rd and 4th generation cephalosporins in poultry production from January 2012. 
default&#xa0;
default&#xa0;
default&#xa0;
default&#xa0;defaultQ. What are the strengths and weaknesses of the Government’s 2013-2018 strategy for tackling antimicrobial resistance? What changes might be made to further strengthen the Government’s action plan?
default&#xa0;
defaultStrengths
default:  realisation that there is a problem and that measure should be undertaken to combat this problem.
default&#xa0;
defaultThe Department of Health 5 year strategy states at Point 2.1, page 8; ‘Increasing scientific evidence suggests that the clinical issues with antimicrobial resistance that we face in human medicine are primarily the result of antibiotic use in people, rather than antibiotics in animals’.
default&#xa0;
defaultWeaknesses
default: lack of willingness to introduce comprehensive legislation to combat resistance development in both the human and veterinary sectors.
default&#xa0;
defaultOctober 2013
default&#xa0;
default&#xa0;
default 
defaulthttp://jac.oxfordjournals.org/content/early/2013/09/13/jac.dkt349.full.pdf+html
default